BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35883451)

  • 21. An N-terminal nucleotide-binding site in VDAC1: involvement in regulating mitochondrial function.
    Yehezkel G; Abu-Hamad S; Shoshan-Barmatz V
    J Cell Physiol; 2007 Aug; 212(2):551-61. PubMed ID: 17503466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Voltage dependent anion channel-1 regulates death receptor mediated apoptosis by enabling cleavage of caspase-8.
    Chacko AD; Liberante F; Paul I; Longley DB; Fennell DA
    BMC Cancer; 2010 Jul; 10():380. PubMed ID: 20646307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VDAC1 cysteine residues: topology and function in channel activity and apoptosis.
    Aram L; Geula S; Arbel N; Shoshan-Barmatz V
    Biochem J; 2010 Apr; 427(3):445-54. PubMed ID: 20192921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miRNA-874-3p inhibits the migration, invasion and proliferation of breast cancer cells by targeting VDAC1.
    Yang H; Wang Z; Hu S; Chen L; Li W; Yang Z
    Aging (Albany NY); 2023 Jan; 15(3):705-717. PubMed ID: 36750173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vdac1 Downregulation Causes Mitochondrial Disintegration Leading to Hippocampal Neurodegeneration in Scopolamine-Induced Amnesic Mice.
    Baghel MS; Thakur MK
    Mol Neurobiol; 2019 Mar; 56(3):1707-1718. PubMed ID: 29916145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis-related VDAC1 regulates the proliferation and apoptosis of osteosarcoma cells via the MAPK signaling pathway.
    Cai X; Zhu S
    Genomics; 2023 May; 115(3):110595. PubMed ID: 36871636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VDAC1, mitochondrial dysfunction, and Alzheimer's disease.
    Shoshan-Barmatz V; Nahon-Crystal E; Shteinfer-Kuzmine A; Gupta R
    Pharmacol Res; 2018 May; 131():87-101. PubMed ID: 29551631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CoQ
    Hseu YC; Thiyagarajan V; Ou TT; Yang HL
    Arch Toxicol; 2018 Jan; 92(1):301-322. PubMed ID: 28918503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.
    Shoshan-Barmatz V; Krelin Y; Shteinfer-Kuzmine A; Arif T
    Front Oncol; 2017; 7():154. PubMed ID: 28824871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Voltage-dependent anion channel 1 (VDAC1) overexpression alleviates cardiac fibroblast activation in cardiac fibrosis via regulating fatty acid metabolism.
    Tian G; Zhou J; Quan Y; Kong Q; Li J; Xin Y; Wu W; Tang X; Liu X
    Redox Biol; 2023 Nov; 67():102907. PubMed ID: 37797372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NRF-1 and HIF-1α contribute to modulation of human VDAC1 gene promoter during starvation and hypoxia in HeLa cells.
    Guarino F; Zinghirino F; Mela L; Pappalardo XG; Ichas F; De Pinto V; Messina A
    Biochim Biophys Acta Bioenerg; 2020 Dec; 1861(12):148289. PubMed ID: 32810507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of VDAC1 prevents Ca²⁺-mediated oxidative stress and apoptosis induced by 5-aminolevulinic acid mediated sonodynamic therapy in THP-1 macrophages.
    Chen H; Gao W; Yang Y; Guo S; Wang H; Wang W; Zhang S; Zhou Q; Xu H; Yao J; Tian Z; Li B; Cao W; Zhang Z; Tian Y
    Apoptosis; 2014 Dec; 19(12):1712-26. PubMed ID: 25342393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction.
    Ben-Hail D; Begas-Shvartz R; Shalev M; Shteinfer-Kuzmine A; Gruzman A; Reina S; De Pinto V; Shoshan-Barmatz V
    J Biol Chem; 2016 Nov; 291(48):24986-25003. PubMed ID: 27738100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lidocaine promotes apoptosis in breast cancer cells by affecting VDAC1 expression.
    Long D; Fang X; Yuan P; Cheng L; Li H; Qu L
    BMC Anesthesiol; 2022 Aug; 22(1):273. PubMed ID: 36042412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VDAC1-interacting anion transport inhibitors inhibit VDAC1 oligomerization and apoptosis.
    Ben-Hail D; Shoshan-Barmatz V
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1612-23. PubMed ID: 27064145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mediation of the antiapoptotic activity of Bcl-xL protein upon interaction with VDAC1 protein.
    Arbel N; Ben-Hail D; Shoshan-Barmatz V
    J Biol Chem; 2012 Jun; 287(27):23152-61. PubMed ID: 22589539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ca(2+)-mediated regulation of VDAC1 expression levels is associated with cell death induction.
    Weisthal S; Keinan N; Ben-Hail D; Arif T; Shoshan-Barmatz V
    Biochim Biophys Acta; 2014 Oct; 1843(10):2270-81. PubMed ID: 24704533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysfunction in the mitochondrial Fe-S assembly machinery leads to formation of the chemoresistant truncated VDAC1 isoform without HIF-1α activation.
    Ferecatu I; Canal F; Fabbri L; Mazure NM; Bouton C; Golinelli-Cohen MP
    PLoS One; 2018; 13(3):e0194782. PubMed ID: 29596470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VDAC1 as a Player in Mitochondria-Mediated Apoptosis and Target for Modulating Apoptosis.
    Shoshan-Barmatz V; Krelin Y; Chen Q
    Curr Med Chem; 2017; 24(40):4435-4446. PubMed ID: 28618997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia.
    Prezma T; Shteinfer A; Admoni L; Raviv Z; Sela I; Levi I; Shoshan-Barmatz V
    Cell Death Dis; 2013 Sep; 4(9):e809. PubMed ID: 24052077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.